Recent relevant Xconomy coverage:
3 – 4:00pm
Registration & Networking
4 – 4:30pm
Spinal Cord Injury Therapies Step Forward
Ethan Perlstein – Chief Scientific Officer, Christopher & Dana Reeve Foundation
Explore the cutting-edge research that could become new therapies for spinal cord injuries and other traumatic neurological damage.
4:30 – 5:00pm
AI Makes Headway Finding New Depression Drugs
Jane Tiller – Chief Medical Officer, BlackThorn Therapeutics
Depression is a particularly challenging area for drug hunters, but BlackThorn Therapeutics says artificial intelligence, brain imaging, and other tools give it an edge finding and developing new medicines.
5 – 5:30pm
An Immunotherapy Approach to Alzheimer’s
Stephanie Yonker – Vice President of Legal, Alector
Does the immune system hold the key to understanding and treating Alzheimer’s disease? Alector is developing a drug that engages an immune cell in the brain to address neurodegeneration.
5:30 – 6:30pm
Drinks & hors d’oeuvres
Schedule is subject to change.